You are not currently logged in
| Local | |
| GMT |
BIOSIMILAR
Mode Strict
In keywords only
Results: 112
U.S. biosimilar approvals may be based more on clinical data vs equivalence 06/09/2010 12:37 GMT- European MAbs biosimilar guidelines may arrive before 2011 - EGA 03/09/2010 14:41 GMT
- EGA head calls for global approach to biosimilars 02/09/2010 15:46 GMT
- Daiichi makes offer for 20% of India's Zenotech 04/08/2010 12:23 GMT
- Sanofi fails to halt immediate sales of generic Lovenox ahead of U.S. court hearing 27/07/2010 17:11 GMT
- Sanofi takes U.S. legal action against FDA to stop Novartis launching generic Lovenox 27/07/2010 12:39 GMT
- Sandoz breaks through Sanofi's defence to win FDA approval of generic Lovenox 26/07/2010 07:28 GMT
- Mylan buys Bioniche for $550 million, creates U.S. hospital-targeted arm 15/07/2010 12:14 GMT
- Hospira's Nivestim approved in EU for preventing chemotherapy neutropenia 10/06/2010 15:09 GMT
- From biosimilars to "bio-betters" - seminar 31/05/2010 07:00 GMT
- Teva copies Roche's cancer drug Rituxan with biosimilar study 26/05/2010 07:00 GMT
- French biotechnology investor predicts sector growth this year 26/05/2010 06:00 GMT
- Italian weekly press review 14/05/2010 11:02 GMT
- English press review - Wednesday 28/04/2010 10:29 GMT
- NICE recommends first biosimilar, priced in branded league 19/03/2010 14:47 GMT
1 of 8
